FDA Approved: SELARSDI — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved SELARSDI (USTEKINUMAB-AEKN) from Teva Pharmaceuticals USA, Inc. under an original Biologics License Application (BLA 761343).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• SELARSDI (USTEKINUMAB-AEKN)

Snippet

ORIG AP for SELARSDI (USTEKINUMAB-AEKN)